262 related articles for article (PubMed ID: 25393117)
21. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
[TBL] [Abstract][Full Text] [Related]
22. Correlation of Prognostic Markers {CEA, Ca19.9, Neutrophil To Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR)} With Progression Free Survival (PFS) in Advanced/Metastatic Gallbladder Carcinoma.
Naik MD; Kataria SP; Kumar G; Singh R
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443542
[TBL] [Abstract][Full Text] [Related]
23. Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution.
Chang H; Gao J; Xu BQ; Guo SP; Lu RB; Li G; Huang SM; Han F; Liu ZG; Tao YL; Tu ZW; Chen C; Li XH; Xia YF
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):639-46. PubMed ID: 23910226
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of neutrophil-to-lymphocyte ratio in advanced nasopharyngeal carcinoma: a large institution-based cohort study from an endemic area.
Yao JJ; Zhu FT; Dong J; Liang ZB; Yang LW; Chen SY; Zhang WJ; Lawrence WR; Zhang F; Wang SY; Sun Y; Zhou GQ
BMC Cancer; 2019 Jan; 19(1):37. PubMed ID: 30621619
[TBL] [Abstract][Full Text] [Related]
25. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.
Huang Z; Liu Y; Yang C; Li X; Pan C; Rao J; Li N; Liao W; Lin L
BMC Cancer; 2018 May; 18(1):515. PubMed ID: 29720123
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.
Inamoto S; Kawada K; Okamura R; Hida K; Sakai Y
Int J Colorectal Dis; 2019 Jul; 34(7):1303-1315. PubMed ID: 31177316
[TBL] [Abstract][Full Text] [Related]
27. The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients.
Jiang R; Zou X; Hu W; Fan YY; Yan Y; Zhang MX; You R; Sun R; Luo DH; Chen QY; Huang PY; Hua YJ; Guo L; Chen MY
Tumour Biol; 2015 Sep; 36(10):7775-87. PubMed ID: 25944165
[TBL] [Abstract][Full Text] [Related]
28. Retrospective study of a novel hematological parameter for predicting the survival of patients with nasopharyngeal carcinoma.
Tang W; Long G
PeerJ; 2024; 12():e17573. PubMed ID: 38915379
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma.
Yamagishi T; Fujimoto N; Nishi H; Miyamoto Y; Hara N; Asano M; Fuchimoto Y; Wada S; Kitamura K; Ozaki S; Kishimoto T
Lung Cancer; 2015 Oct; 90(1):111-7. PubMed ID: 26259877
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
31. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
[TBL] [Abstract][Full Text] [Related]
32. Triglyceride-inflammation score established on account of random survival forest for predicting survival in patients with nasopharyngeal carcinoma: a retrospective study.
Li J; Ye Y; Cai Y; Ji H; Qin W; Luo Y; Zhou X; Zhang Z; Xiao X; Zhang B
Front Immunol; 2024; 15():1375931. PubMed ID: 38736892
[TBL] [Abstract][Full Text] [Related]
33. [Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].
Wang CT; Cao KJ; Li Y; Xie GF; Huang PY
Ai Zheng; 2007 Feb; 26(2):212-5. PubMed ID: 17298756
[TBL] [Abstract][Full Text] [Related]
34. Long term outcomes and prognostic factors of n0 stage nasopharyngeal carcinoma: a single institutional experience with 610 patients.
Sun JD; Chen CZ; Chen JZ; Li DS; Chen ZJ; Zhou MZ; Li DR
Asian Pac J Cancer Prev; 2012; 13(5):2101-7. PubMed ID: 22901177
[TBL] [Abstract][Full Text] [Related]
35. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
[TBL] [Abstract][Full Text] [Related]
36. Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer.
Hwang EC; Hwang IS; Yu HS; Kim SO; Jung SI; Hwang JE; Kang TW; Kwon DD; Park K; Ryu SB
Jpn J Clin Oncol; 2012 Oct; 42(10):955-60. PubMed ID: 22844127
[TBL] [Abstract][Full Text] [Related]
37. Comparison of inflammation-based prognostic scores as predictors of survival outcomes in patients with germ cell tumors.
Yoshinaga K; Sadahira T; Maruyama Y; Mitsui Y; Iwata T; Wada K; Araki M; Watanabe T; Nasu Y
Investig Clin Urol; 2021 Jan; 62(1):47-55. PubMed ID: 33314803
[TBL] [Abstract][Full Text] [Related]
38. Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis.
Yang L; Xia L; Wang Y; Hong S; Chen H; Liang S; Peng P; Chen Y
PLoS One; 2016; 11(7):e0158853. PubMed ID: 27399281
[TBL] [Abstract][Full Text] [Related]
39. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
40. The Glasgow prognostic score as a prognostic factor in patients with advanced non-small cell lung cancer treated with cisplatin-based first-line chemotherapy.
Jiang AG; Lu HY
J Chemother; 2015 Feb; 27(1):35-9. PubMed ID: 24716851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]